YJ

Active Director Director DIN 10045204
DIN 10045204 First appointment Feb 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Yongsu Jo

Data last updated:

Yongsu Jo is a Director at Micobio India Private Limited (since 2023). The company operates in Healthcare. Micobio India Private Limited reported revenue of ₹11.5 Lakh (FY 2024).

DIN 10045204
Primary Designation Director
Industry Healthcare
First Appointment 15 Feb 2023
Oldest Company Age 3 yrs
Largest company Micobio India Private Limited · ₹11.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Micobio India Private Limited U62020HR2022FTC107735
Director15 Feb 20232022₹11.5 Lakh (FY 2024)Active

Board colleagues of Yongsu Jo

NameDINCompanyDesignation
Mohd Nomanul Haq10701979Micobio India Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Micobio India Private Limited
Premium access

Shareholding and investment profile for Yongsu Jo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yongsu Jo

Yongsu Jo currently holds 1 directorship: Micobio India Private Limited (Director, since 15 Feb 2023, revenue ₹11.5 Lakh (FY 2024)).

Yongsu Jo was first appointed on 15 Feb 2023 as Director at Micobio India Private Limited.

The current boards of Yongsu Jo's companies include Mohd Nomanul Haq (Micobio India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available